MedTrace Logo

ICG Anastomotic Control in Digestive System Surgery

NCT06270745 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-02-23

No results posted yet for this study

Summary

This was a parallel single-center retrospective cohort study conducted at Linglong Yingcheng Hospital, Shandong, China. The purpose of this study was to investigate the effect of indocyanine green (ICG) on patients undergoing digestive system surgery (subtotal gastrectomy, partial hepatectomy, transverse colectomy, left colectomy, including sigmoid resection, and splenic colic resection). ) of anastomotic leakage (AL). Secondary objectives were to detect and study the impact of various risk factors on AL and on morbidity and surgical performance within 30 days of surgery.

Conditions

  • Surgical Anastomosis

Interventions

DRUG

indocyanine green

Whether to use ICG to assess anastomotic perfusion during digestive system surgery

Sponsors & Collaborators

  • Shandong Linglong Yingcheng Hospital

    lead NETWORK

Principal Investigators

  • Xuan Qiu, MD · Shandong Linglong Yingcheng Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2024-02-01
Completion
2024-06-01
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06270745 on ClinicalTrials.gov